NCT02359435View on ClinicalTrials.gov

Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection

NACompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Reverse hybrid therapy

pantoprazole 40 mg b.d., amoxicillin 1 g b.d., clarithromycin 500 mg b.d. and metronidazole 500 mg b.d. for the first 7 days, followed by pantoprazole 40 mg b.d. and amoxicillin 1 g b.d. for another 5 days

DRUG

Standard triple therapy

pantoprazole 40 mg b.d., clarithromycin 500 mg b.d., and amoxicillin 1 g b.d. for 12 days

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

lead

Kaohsiung Veterans General Hospital.

OTHER

NCT02359435 - Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter